Human hematopoietic neoplasms, leukemias and lymphomas are very often associated with chromosomal abnormalities such as chromosomal translocations and inversions, which are believed to play crucial roles in pathogenesis of malignant diseases because chromosome abnormalities can activate c-oncogenes by juxtaposing them to actively transcribed loci. About 90% of follicular lymphoma of B-cell origin, one of the most common hematopoietic malignancies, carry a specific chromosomal translocation between chromosome 14 and 18, t(14;18). By cloning the joining region of the translocation, we have identified a gene that has been named bcl-2. All t(14;18) translocations studied thus far occur within or in close proximity to the bcl-2 gene, and the level of bcl-2 MRNA and transcription of tranlocated bcl-2 allele are elevated in the lymphoma cells with the t(14;18) translocation. These make the bcl-2 gene a strong candidate for the gene which plays the dominant role in follicular lymphomagenesis. We propose to analyze the function of the bcl-2 protein. We constructed the high expression forms of the bcl-2 gene and introduced into B cell lines. Our preliminary results indicate that a high level of bcl-2 protein reduced serum requirement for growth of B cell line. The effect on cell growth by bcl-2 protein will be studied in more detail by assaying the growth potential in soft agar and in serumdeprived nedium, and the plating, efficiency after serial dilution and tumorigencity in athymic mice. We will then determine which lymphokine(s) is involved in growth advantages given to 8 cells by high levels of bcl-2 protein. The cell lineagespecificity of the growth effect produced by bcl.2 protein also will be analyzed. A series of mutant bcl-2 genes will be generated and used to determine the region of the bcl-2 protein that are important for the growth-enhancing activity of the protein. These studies can help to define the molecular basis of B cell malignancy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA050551-03
Application #
3195096
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1989-08-15
Project End
1994-05-31
Budget Start
1991-06-01
Budget End
1992-05-31
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Hermonat, P L; Santin, A D; De Greve, J et al. (1999) Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter. J Hum Virol 2:359-68
Givol, I; Tsarfaty, I; Resau, J et al. (1994) Bcl-2 expressed using a retroviral vector is localized primarily in the nuclear membrane and the endoplasmic reticulum of chicken embryo fibroblasts. Cell Growth Differ 5:419-29
Pettersson, M; Jernberg-Wiklund, H; Larsson, L G et al. (1992) Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells. Blood 79:495-502
Borzillo, G V; Endo, K; Tsujimoto, Y (1992) Bcl-2 confers growth and survival advantage to interleukin 7-dependent early pre-B cells which become factor independent by a multistep process in culture. Oncogene 7:869-76
Eguchi, Y; Ewert, D L; Tsujimoto, Y (1992) Isolation and characterization of the chicken bcl-2 gene: expression in a variety of tissues including lymphoid and neuronal organs in adult and embryo. Nucleic Acids Res 20:4187-92
Garcia, I; Martinou, I; Tsujimoto, Y et al. (1992) Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258:302-4
Endo, K; Borer, C H; Tsujimoto, Y (1991) Modulation of LFA-1 surface antigen expression by activated H-ras oncogene in EBV-infected human B-lymphoblast cells. Oncogene 6:1391-6
Adachi, M; Tsujimoto, Y (1990) Potential Z-DNA elements surround the breakpoints of chromosome translocation within the 5' flanking region of bcl-2 gene. Oncogene 5:1653-7
Nelson, J A; Ghazal, P; Wiley, C A (1990) Role of opportunistic viral infections in AIDS. AIDS 4:1-10